 NEW YORK and CLEVELAND, Feb. 02, 2021 GLOBE NEWSWIRE -- Abeona Therapeutics Inc. Nasdaq: ABEO, a fully-integrated leader in gene and cell therapy, today announced that it will host a live webinar for the investment community on Tuesday, February 16, 2021 at 1:00 p.m. EST to review clinical data on the companys investigational AAV-based gene therapies ABO-102 and ABO-101 presented at the 17th Annual WORLDSymposiumTM. 